Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514160 | SCV000609646 | likely benign | not provided | 2017-08-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000514160 | SCV001061121 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514160 | SCV001777853 | benign | not provided | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514160 | SCV003916788 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | KMT2A: BS1 |
Prevention |
RCV003942671 | SCV004775157 | likely benign | KMT2A-related disorder | 2021-09-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ambry Genetics | RCV004023476 | SCV004896183 | likely benign | Inborn genetic diseases | 2021-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |